InMode Ltd.’s stock INMD rose 2.5% premarket Wednesday, after the Israeli medical tech company offered second-quarter guidance that topped estimates and raised its full-year revenue guidance. The company said it expects second-quarter EPS of 70 cents to 71 cents on revenue of $135.7 million to $135.9 million. The FactSet consensus is for EPS of 64 cents and revenue of $130.0 million.
5% premarket Wednesday, after the Israeli medical tech company offered second-quarter guidance that topped estimates and raised its full-year revenue guidance. The company said it expects second-quarter EPS of 70 cents to 71 cents on revenue of $135.7 million to $135.9 million. The FactSet consensus is for EPS of 64 cents and revenue of $130.0 million.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite: